3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
27
Gastrointestinal
9
Breast
9
Thoracic
4
Head & Neck
2
Gynecologic
2
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Multiple Myeloma
7
Neoplasms, Plasma Cell
2
Neoplasms
2
Lymphoma
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Thyroid Neoplasms
1
Thyroid Diseases
1
Prostatic Neoplasms
1
Pain
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
Specimen Handling
4
Zoledronic Acid
3
Vorinostat
3
Azacitidine
3
venetoclax
2
trametinib
2
ruxolitinib
2
pertuzumab
2
palbociclib
2
dabrafenib
2
copanlisib
2
abiraterone
2
Sunitinib
2
Sorafenib
2
Oxaliplatin
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Immunoglobulin G
2
HhAntag691
2
Fluorouracil
2
Doxorubicin
2
Disulfides
2
Dasatinib
2
Clodronic Acid
2
Bevacizumab
2
Afatinib
2
Ado-Trastuzumab Emtansine
2
2C4 antibody
2
ulixertinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Interviews as Topic
×
Plasma cell
×
Clear all
NCT06236373
2024-12-09
Survivorship
University of Modena and Reggio Emilia
Recruiting
45 enrolled